🇺🇸 FDA
Patent

US 9658230

Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

granted A61KA61K39/40A61K45/06

Quick answer

US patent 9658230 (Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB) held by Ludwig-Maximilians-Universitat Munchen expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K39/40, A61K45/06, A61P, A61P15/14